share_log

Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target

Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target

Needham重申买入Cogent Biosciences,维持18美元的目标股价
Moomoo 24/7 ·  02/26 04:59

Needham analyst Ami Fadia reiterates Cogent Biosciences (NASDAQ:COGT) with a Buy and maintains $18 price target.

尼德姆分析师阿米·法迪亚重申了Cogent Biosciences(纳斯达克股票代码:COGT)的买入并维持18美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发